Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
DGHM & VAAM 2024
Programm
Poster
Personen
Suche
DE
Poster zum Thema "Healthcare-associated infections and pathogens: Prevention, surveillance, outbreaks und antibiotic stewardship"
Zurück
P-HAIP-001
EC-COMPASS: Long-term, Multi-Centre Surveillance of Enterobacter cloacae complex – an Interpretive Clinical Viewpoint
Maximilian Mauritz (Datteln / DE)
Johannes Forster (Würzburg / DE)
P-HAIP-002
High hydrostatic pressure as a means to eliminate bacteria from bone tissue
Henrike Loeffler (Rostock / DE)
P-HAIP-003
The influence of established and novel antibiotics on the activity of the WalRK and the LiaRS two-component systems of Bacillus subtilis
Maike Karcher (Bonn / DE)
P-HAIP-005
Behaviour of Candida auris and Candida parapsilosis in comparison to other Candida species in laundry hygiene tests according to EN 17658
Britta Brands (Kleve / DE)
P-HAIP-006
Application of Fourier-transform infrared spectroscopy for typing in a neonatal Kluyvera ascorbata clinical outbreak
Miriam Cordovana (Bremen / DE)
P-HAIP-007
Tackling the mechanism of species-specific drug combinations in bacteria
Martina Airoldi (Tübingen / DE)
P-HAIP-008
Impact of gender, medical qualifications and area population on the heads of municipal public health departments during the SARS-CoV-2/COVID-19 pandemic
Sabine Trommer (Jena / DE)
P-HAIP-009
Evaluation of the Vivalytic one Analyser for detecting uropathogenic bacteria and antimicrobial resistances in urine samples of urological patients
Jessica Hartmann (Giessen / DE)
P-HAIP-010
Development of the consumption of reserve-antibiotics in German acute care hospitals from 2018 to 2022
Birgitta Schweickert (Berlin / DE)
P-HAIP-011
Phenotypic within-host evolution of vancomycin-resistant Enterococcus faecium
Vera Blaschke (Würzburg / DE)
P-HAIP-012
Characterising a cluster of NDM-5-positive Escherichia coli clinical isolates
Kyriaki Xanthopoulou (Köln / DE)
P-HAIP-013
The Flavin Transferase ApbE as a key drug target - structural revelations for antibiotic discovery
Mustafa Zeno (Stuttgart / DE)
P-HAIP-014
Microbiological evaluation of an anti-infective biopolymer implant coating with two modes of operation
Melanie Nonhoff (Münster / DE)
P-HAIP-015
Genome-oriented outbreak identification reveals a gross overestimation of outbreak frequency for vancomycin-resistant Enterococcus faecium
Anca Rath (Regensburg / DE)
P-HAIP-016
The effect of serum origin on the anti-infective properties of a biopolymer implant coating containing silver Ions
Melanie Nonhoff (Münster / DE)
P-HAIP-018
Reduction and inactivation of microorganisms with tolerance to quaternary ammonium compounds by chlorine dioxide
Thorsten Kuczius (Münster / DE)
P-HAIP-019
The Risk of Bloodstream Infections in Patients with Central Venous Access Port in Non-ICUs in Germany
Beate Weikert (Berlin / DE)
P-HAIP-020
Demonstrating shedding of vancomycin-resistant Enterococcus faecium (VREfm) into the hospital environment by colonized patients based on typing by whole genome sequencing
Nataliya Kucheryava (Göttingen / DE)
P-HAIP-021
Systematic screening of 42 major VRE Enterococcus faecium strains towards changes in the antibiotic resistance, biofilm formation and desiccation tolerance after exposure to simulated microgravity
Franca Arndt (Köln / DE)
P-HAIP-022
Determination of cgMLST Thresholds for MRSA, MDR E. coli, and VRE by correlating molecular typing data with epidemiological information
Hauke Tönnies (Münster / DE)
P-HAIP-023
Strengthening Molecular Surveillance of ARIs in Bavaria: Expansion of the Bavarian Influenza + Corona Sentinel (BIS+C)
Jennifer Flechsler (Oberschleißheim / DE)
P-HAIP-024
EU targets for 2030 from the European action plan to combat antimicrobial resistance: how do German federal states compare in the outpatient sector? Germany, 2019-2022.
Susanne Barbara Schink (Berlin / DE)
P-HAIP-025
Microbiological epidemiology in patients undergoing allogeneic hematopoietic stem cell transplantation (2015-2020) – first results of a retrospective cohort study
Claas Baier (Hannover / DE)
P-HAIP-026
Zapnometinib as a new antibacterial compound targeting cell division of Streptococcus pneumoniae
Jasmin Jacob (Münster / DE)
P-HAIP-027
Connecting actual user data from SARS‑CoV‑2 test centers with a user survey in a mid-sized German city
Marcus Grohmann (Bamberg / DE)
P-HAIP-028
Zapnometinib: An antiviral and antibacterial agent for combatting Streptococcus pneumoniae infections with synergistic effects with penicillin
Michelle Wert (Münster / DE)
P-HAIP-029
Identification of risk factors for long-term persistence of linezolid resistant enterococci - experiences from a tertiary care centre
Vera Rauschenberger (Würzburg / DE)
P-HAIP-030
From airport to school to hospital -
An Outbreak of SARS-CoV-2 Infections Among German Schoolchildren Caused by A Hitherto Rare Viral Variant
Sven Sachse (Essen / DE)
Ivana Kraiselburd (Essen / DE)
Ricarda Schmithausen (Essen / DE)
P-HAIP-031
A new antibiotic: Evaluation of a Photoactivatable Ciprofloxacin and the role of Bile Acids to diminish Biofilms on Bile Duct Catheters
Anne Busch (Jena / DE)
P-HAIP-032
Exploring the pathogen-killing potential of AGXX
®
surfaces: A game-changer in antimicrobial technology for healthcare settings
Daniela Wischer (Berlin / DE)
P-HAIP-033
Medical tourists – a source of imported pathogens? – A review of Methicillin-Resistant Staphylococcus aureus (MRSA)-, Multiresistant Gram-negative bacteria (MRGN)-admission-screenings in Arab and Russian medical tourists at University Hospital Düsseldorf (UKD) from 2017 to 2021
Annette Eyking-Singer (Bochum / DE)
P-HAIP-034
Localisation of indication-based hand desinfections.
Dominik Sons (Köln / DE)
P-HAIP-035
Touching surfaces- antibacterial surfaces for spaceflight and clinical applications
Carolin L. Krämer (Rheinbach / DE; Köln / DE)
P-HAIP-036
Detection of SARS-CoV-2 RNA in stool samples from patients with acute gastroenteritis during a low prevalence endemic period in summer 2023
Frauke Mattner (Köln / DE)
P-HAIP-037
Prevalence of co-colonisation of multidrug-resistant organisms in intensive care.
Beate Schlosser (Berlin / DE)
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz